Changes over time in Uric Acid in relation to Changes in Insulin Sensitivity, Beta-cell Function, and Glycemia.
Serum uric acid has been linked to risk of type 2 diabetes (T2DM) but debate persists as to whether it plays a causal role. Indeed, it is unclear if changes in uric acid relate to the pathophysiologic determinants of T2DM (insulin resistance, beta-cell dysfunction), as would be expected if causal. To evaluate the impact of changes in uric acid over 2-years on changes in insulin sensitivity, beta-cell function and glycemia in women with and without recent gestational diabetes (GDM), a model of the early natural history of T2DM. At both 1- and 3-years postpartum, 299 women (96 with recent GDM) underwent uric acid measurement and oral glucose tolerance tests that enabled assessment of insulin sensitivity/resistance (Matsuda index, Homeostasis Model Assessment (HOMA-IR)), beta-cell function (Insulin Secretion-Sensitivity Index-2 (ISSI-2), insulinogenic index/HOMA-IR (IGI/HOMA-IR)), and glucose tolerance. Women with recent GDM had higher serum uric acid than their peers at both 1-year (281±69 vs 262±58 μmol/l, p=0.01) and 3-years postpartum (271±59 vs 256±55 μmol/l, p=0.03), coupled with lower insulin sensitivity, poorer beta-cell function, and greater glycemia (all p<0.05). However, on fully-adjusted analyses, neither uric acid at 1-year nor its change from 1-to-3-years was independently associated with any of the following metabolic outcomes at 3-years postpartum: Matsuda index, HOMA-IR, ISSI-2, IGI/HOMA-IR, fasting glucose, 2-hour glucose, or glucose intolerance. Serum uric acid does not track with changes over time in insulin sensitivity, beta-cell function or glycemia in women with recent GDM, providing evidence against causality in its association with diabetes.